[1] |
胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(6): 500-504. doi:10.19983/j.issn.2096-8493.2024164.
|
[2] |
World Health Organization. Global Tuberculosis Programme.Global tuberculosis control:WHO report. Geneva: World Health Organization, 2023.
|
[3] |
Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections-a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci, 2020, 27(1): 74. doi:10.1186/s12929-020-00667-6.
pmid: 32552732
|
[4] |
Bloom BR, Atun R, Cohen T, et al. Tuberculosis. 3rd ed. Washington: The International Bank for Reconstruction and Development/The World Bank ;2017.
|
[5] |
Heidary M, Shirani M, Moradi M, et al. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment. Eur J Microbiol Immunol (Bp), 2022, 12(1): 1-17. doi:10.1556/1886.2021.00021.
|
[6] |
Yadav S, Rawal G, Jeyaraman M, et al. Advancements in Tuberculosis Diagnostics: A Comprehensive Review of the Critical Role and Future Prospects of Xpert MTB/RIF Ultra Technology. Cureus, 2024, 16(3): e57311. doi:10.7759/cureus.57311.
|
[7] |
Zaporojan N, Negrean RA, Hodian R, et al. Evolution of Laboratory Diagnosis of Tuberculosis. Clin Pract, 2024, 14(2): 388-416. doi:10.3390/clinpract14020030.
|
[8] |
Ghebrekristos YT, Beylis N, Centner CM, et al. Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation. Lancet Microbe, 2023, 4(10): e822-e829. doi:10.1016/S2666-5247(23)00169-6.
|
[9] |
Pantoja A, Kik SV, Denkinger CM. Costs of novel tuberculosis diagnostics--will countries be able to afford it? J Infect Dis, 2015, 211 Suppl 2: S67-77. doi:10.1093/infdis/jiu820.
|
[10] |
Lee YJ, Shin S, Roh EY, et al. Acceptability of sputum specimens for diagnosing pulmonary tuberculosis. J Korean Med Sci, 2015, 30(6): 733-736. doi:10.3346/jkms.2015.30.6.733.
pmid: 26028925
|
[11] |
Zhang H, Li H, Tan M, et al. GeneXpert MTB/RIF combined with conventional methods for tuberculosis in Shanghai Regional Medical Center: a retrospective diagnostic study. Ann Transl Med, 2022, 10(10): 575. doi:10.21037/atm-22-1374.
pmid: 35722378
|
[12] |
Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis, 2013, 13(4): 349-361. doi:10.1016/S1473-3099(13)70008-2.
pmid: 23531388
|